● Program Day 1, Sep. 2 ● Program Day 2, Sep. 3 Program Day 1, Sep. 2 Session Topics Speaker Chair 0830-0900 Opening Ceremony Rin YAMAGUCHI (Fukuoka) Hirohisa YANO (Fukuoka) Shoshu MITSUYAMA (Fukuoka) Philip IAU (Singapore) Session I Platform     0900-0908 Quality assurance of mammographic images with PGMI rating system Alta YT LAI (Hong Kong)   Michiyo SAIMURA (Fukuoka), Chui-Mei TIU (Taipei) 0908-0916 Comparison of full field digital mammography (FFDM) with synthesized 2D mammography (SM) and digital breast tomosynthesis (DBT) in Chinese women Christine SY LO (Hong Kong) 0916-0924 Digital breast tomosynthesis with synthetic views (DBT+C-views) versus full-field digital mammography (FFDM): early local experience in Chinese screening population Ophelia KH WAI (Hong Kong) 0924-0932 Evaluation of personalized mammography screening system with supplemental whole breast ultrasound enabled by fully automated 3D breast density assessment software Kiyoshi NAMBA (Hokkaido) 0932-0940 Correlation between ultrasound characteristics and NGX6 mRNA expression of breast mass in Indonesia Lina CHORIDAH (Yogyakarta) 0940-0948 Biological significance of the wild-type p53-induced phosphatase 1(Wip1) expression in invasive breast cancer Yuka INOUE (Fukuoka) 0948-0956 PD-L1 expression is associated with increased tumor-infiltrating lymphocytes in triple negative breast cancer Hitomi MORI (Fukuoka)   Coffee break     Session II Mammography     1010-1035 Mammography BI-RADS Humairah Samad CHEUNG (Kuala Lumpur)   Henry HS LAM (Hong Kong), Hideya TAKEUCHI (Oita) 1035-1100 Mammography: Japanese classification (vs BIRADS) Kenji FUJIYOSHI (Oita) 1100-1125 Breast cancer and mammography in Thailand Malai MUTTARAK (Chiang Mai) Session III Ultrasound     1130-1155 BI-RADS for ultrasound Daniel MAKES (Jakarta)   Chun-Ying LUI (Hong Kong), Ryoji WATANABE (Fukuoka) 1155-1220 Japanese ultrasound breast imaging reporting and data system Kazutaka NAKASHIMA (Okayama) 1220-1245 Ultrasound in the diagnosis and screening of breast cancer in Taiwan Yi-Hong CHOU (Taipei) Luncheon Luncheon 1     1300-1350 The emerging role of breast tomosynthesis in breast imaging (sponsored by Hologic Japan, Inc) Takayoshi UEMATSU (Shizuoka)   Chun-Ying LUI (Hong Kong) Session IV Translational & Diagnostic Research     1405-1430 Genomic studies of breast fibroepithelial tumors Bin Tean TEH (Singapore)   Puay Hoon TAN (Singapore), Eriko TOKUNAGA (Fukuoka) 1430-1455 Functions of androgens and other non-estrogen/progesterone steroid receptors in triple negative breast cancer patients Keely MCNAMARA (Miyagi) 1455-1520 Epithelial paradox: clinical significance of E-cadherin and vimentin expression pattern in invasive breast cancer Nami YAMASHITA (Fukuoka)   Coffee break     Session V Borderline Lesions & Ductal Carcinoma in situ 1535-1600 Classification of borderline breast lesions and the clinical implications Puay Hoon TAN (Singapore)   Michael BILOUS (Sydney), Seigo NAKAMURA (Tokyo) 1600-1625 Which patterns of breast calcifications can be monitored? Are mammography studies solely adequate for determining diagnosis? Yumi MIYAGI (Tokyo) 1625-1650 How should we manage borderline lesions of the breast as surgeons? Hiroshi YAGATA (Saitama) Session VI Heredity Breast Cancer     1655-1720 Genetic predisposition to breast cancer Philip IAU (Singapore)   Hirotaka IWASE (Kumamoto), Bin Tean TEH (Singapore) 1720-1745 The current status and the future perspectives for hereditary breast and ovarian cancer (HBOC) in Japan Seigo NAKAMURA (Tokyo) 1745-1750 Message from the President of Japanese Breast Cancer Society Seigo NAKAMURA (Tokyo) 1750-1800 Message from the Presidents of Asian Breast Diseases Association Philip IAU (Singapore) Yi-Hong CHOU (Taipei)   Poster Presentation (Wine & Cheese)     1800-1830 (A) Mammography Candice CH GOH Lorraine HY SINN Ophelia KH WAI   Syoji KUROKI (Fukuoka), Malai MUTTARAK (Chiang Mai) 1800-1840 (B) Imaging & pathology Jeanie B CHIANG (2) Visnja V BAKSA REYNOLDS Alta YT LAI Alexander CW LEE   Kazutaka NAKASHIMA (Okayama), Hiroshi YAGATA (Saitama) 1800-1845 (C) Translational research for clinical use Toshiaki AKAHANE Ichiro MAEDA Yun-Bi NI Mina OKABE Shuko SAKU Kimihiro TANAKA   Keely MCNAMARA (Miyagi), Masahiro OIKAWA (Fukuoka) 1920- Congress Dinner at Chikae     Program Day 2, Sep. 3 Session Topics Speaker Chair Session VII Clinical Use of Molecular Markers     0800-0825 Gene expression profiling and personalized therapy in breast cancer Takayuki IWAMOTO (Okayama)   Hirofumi MATSUMOTO (Okinawa), Reiki NISHIMURA (Kumamoto) 0825-0850 Importance of proper Ki-67 scoring for accurate assessment for prognosis and selection of treatment strategy in patients with breast cancer Nobuyuki ARIMA (Kumamoto) 0850-0915 Prognostic and predictive markers in breast cancer Gary TSE (Hong Kong) Session VIII Biology of Breast Cancer Subtypes     0920-0940 Relationships between low- and high-grade pathways and the subtypes of ductal carcinoma in situ Rin YAMAGUCHI (Fukuoka)   Michael BILOUS (Sydney), Masaya KAI (Fukuoka) 0940-1005 Triple negative breast cancer: Is hope around the corner? Makoto KUBO (Fukuoka) 1005-1030 The correlation between breast cancer biology and radiological findings Kentaro TAMAKI (Okinawa)   Coffee break     Session IX Updated Therapeutic Strategies     1045-1110 Treatment strategy for postmenopausal women with ER-positive/HER2-negative metastatic breast cancer Yutaka YAMAMOTO (Kumamoto)   Keisei ANAN (Fukuoka), Miki YAMAGUCHI (Fukuoka) 1110-1135 Updates therapeutic strategies in HER2-positive breast cancer Masaya HATTORI (Aichi) 1135-1200 Updates therapeutic strategies in triple negative breast cancer Hiroji IWATA (Aichi) Luncheon Luncheon 2     1215-1305 Issues in HER2 testing in breast cancer - application of the 2013 ASCO/CAP guidelines to laboratory practice (sponsored by Chugai Pharmaceutical Co., Ltd.) Michael BILOUS (Sydney)   Gary TSE (Hong Kong)   Poster Presentation     1315-1340 (D) Subtype and treatment Sayuri AKIYOSHI Akira I. HIDA Shigeto MAEDA   Masahiro KASHIWABA (Miyazaki), Gary TSE (Hong Kong) 1315-1340 (E) Recent advances in breast imaging Sayaka SAKURAI Visnja V BAKSA REYNOLDS Ting WONG   Henry HS LAM (Hong Kong), Mitsuhiro TOZAKI (Kagoshima) 1315-1340 (F1) Pathology & case report Kansei KOMAKI Han Boon OH Michiyo SAIMURA   Michael BILOUS (Sydney), Shigeki MINAMI (Nagasaki) 1315-1340 (F2) Others & case report Yasuko MIZUSHIMA Ryoko OI Emi TAKAZAKI   Takashi NAKAMURA (Mie), Kanou UEHARA (Okinawa) Session X1 New Therapeutic Application     1345-1410 Accelerated partial-breast irradiation for early breast cancer using proton radiation therapy (initial clinical experience: phase I/ II study) Etsuyo OGO (Fukuoka)   Keiko MIYAZATO (Okinawa), Tomofumi OSAKO (Kumamoto) 1410-1435 Circulating tumor cells: their clinical application and therapeutic potential Takayuki UENO (Tokyo) 1435-1455 The clinical development of therapeutic peptide vaccines for breast cancer treatment Uhi TOH (Fukuoka) Session X2 Breast Pathology Update [Venue: Eisai Fukuoka office (Bivi Fukuoka 6F)] 14:00-16:30 1405-1435 WHO breast classification - updates in 2016 Puay Hoon TAN (Singapore)   Oi HARADA (Tokyo), Ichiro MAEDA (Kanagawa) 1445-1630 Case Presentation Oi HARADA Akira HIDA Naoki KANOMATA Yuji KOZUKA Hajime KURODA Ichiro MAEDA Hirofumi MATSUMOTO Suzuko MORITANI Rieko NISHIMURA   Michael BILOUS (Sydney), Shotaro MAEDA (Tokyo), Puay Hoon TAN (Singapore), Gary TSE (Hong Kong), Shin-ichi TSUCHIYA (Nagano) Session XI Recent Advances in Imaging     1500-1525 Recent advances in MRI and PET Mitsuhiro TOZAKI (Kagoshima)   Yi-Hong CHOU (Taipei), Hiroshi NAKAHARA (Miyazaki) 1525-1550 Innovation for imaging: breast ultrasound Takeshi UMEMOTO (Ibaraki) 1550-1610 The potential of nanotechnology for breast cancer imaging Nobutaka IWAKUMA (Fukuoka) 1610-1635 Treatment of breast fibroadenoma with high intensity focused ultrasound David BRENIN (Charlottesville)   Coffee break     Session XII Breast Cancer Immunology     1650-1710 Tumor infiltrating lymphocyte (TIL) in early breast cancer Michi MORITA (Nagasaki)   Shigeto MAEDA (Nagasaki), Uhi TOH (Fukuoka) 1710-1735 The clinical impact of tumor infiltrating lymphocytes and these alterations after treatment in advanced breast cancer Minoru MIYASHITA (Miyagi) 1735-1800 Assessment and clinical implications of tumor infiltrating lymphocyte in breast cancer Tomoharu SUGIE (Osaka) 1800-1805 Closing Ceremony     *Best Abstract Award Ceremony (Prizes will be awarded to the top three abstracts submitted to the ABDA2016.)       Maki TANAKA (Fukuoka) Philip IAU (Singapore) Rin YAMAGUCHI (Fukuoka) *Program contents may change without prior notice. page top